Joseph Larosa - Dec 8, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Stock symbol
REGN
Transactions as of
Dec 8, 2021
Transactions value $
-$7,618,479
Form type
4
Date filed
12/10/2021, 04:30 PM
Previous filing
Aug 24, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +3.34K +25.32% $0.00 16.5K Dec 8, 2021 Direct F1
transaction REGN Common Stock Options Exercise $5.37M +30K +181.6% $179.13 46.5K Dec 9, 2021 Direct
transaction REGN Common Stock Tax liability -$13M -19.8K -42.5% $657.11 26.7K Dec 9, 2021 Direct
holding REGN Common Stock 3.19K Dec 8, 2021 2021 GRAT
holding REGN Common Stock 314 Dec 8, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30K -100% $0.00* 0 Dec 9, 2021 Common Stock 30K $179.13 Direct F2
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +14.3K $0.00 14.3K Dec 8, 2021 Common Stock 14.3K $644.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.